Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features.

HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features. Abstract Text:

    fusheng liFusheng Li,helen hortonHelen Horton,peter b gilbertPeter B Gilbert,juliana m mcelrathJuliana M McElrath,lawrence coreyLawrence Corey,steve g selfSteve G Self,

    Much of the current effort in HIV-1 vaccine design is directed at achieving T-cell immunity that will result in enough immunological memory to contain HIV-1 infection after acquisition. However, antigenic diversity, plus a lack of understanding of HIV-1 vaccine immunology, have hindered the development of a globally effective cytotoxic T-lymphocyte (CTL)-based vaccine. Cellular response, in using a finite immune system to recognize an infinite number of potential pathogens, exhibits a series of parsimonious features. These features are considered critical in modulating HIV-1 vaccine multiple specificities. We took the features into consideration when the potential epitope coverage (E(c)) to circulating strains by current vaccine strategies was analyzed. Based on these analyses, several approaches are proposed to enhance the breadth of vaccine responses and, hence, the potential protective efficacy.

    HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features. Publishing Authors By Initials

    f liF Li,h hortonH Horton,pb gilbertPB Gilbert,jm mcelrathJM McElrath,l coreyL Corey,sg selfSG Self,

    For similar therapeutics: biological therapy: immunotherapy: immunization: immunotherapy, active: vaccination research abstracts see: therapeutics: biological therapy: immunotherapy: immunization: immunotherapy, active: vaccination research

    PUBMED ID PMID:

    MEDLINE DATE:

    HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Current HIV research

    VOLUME: 5

    Page Numbers: 97-107

    Journal Abbreviation: Curr. HIV Res.

    ISSN: 1873-4251

    DAY: 3

    MONTH: Jan

    YEAR: 2007

    HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101156990

    HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features. Keywords Mesh Terms:

    KEYWORDS: Vaccination

    MESH TERMS: immunology

    Chemical & Substance for Abstract: HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features. Information

    Substance Name: Epitopes

    Registry Number: 0

    Grant and Affiliation Information for HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features.

    AFFILIATION: Statistical Center for HIV/AIDS Research and Prevention, 1100 Fairview Avenue N, Seattle, WA 98109, USA. Fusheng@scharp.org.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY: United States NIAID

    GRANT: 5U1AI046703-05

    ACRONYM: AI

    MEDLINETA: Curr HIV Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News